S | Age | M/F (n) | BMI | IPAQ | %PMHR | MaxW | MaxRPE | MRS onset |
---|---|---|---|---|---|---|---|---|
1 | 25.8 ± 6.4 | 3/5 | 24.0 ± 2.7 | 98.7 ± 109 | 85.5 ± 4.3 | 168 ± 43 | 6.4 ± 1.4 | 14.6 ± 2.4 |
2V | 28.1 ± 9.9 | 2/6 | 23.6 ± 2.7 | 36.4 ± 15.4 | 94.3 ± 7.3 | 189 ± 63 | 7.7 ± 0.9 | 12.8 ± 0.8 |
2A | 28.1 ± 10.7 | 2/6 | 23.3 ± 2.2 | 66.8 ± 53.6 | 93.5 ± 8.7 | 179 ± 58 | 8.2 ± 1.2 | 13.3 ± 2.0 |
3 | 26.6 ± 7.5 | 6/2 | 23.0 ± 1.7 | 61.6 ± 47.4 | 89.3 ± 5.3 | 161 ± 44 | 7.5 ± 0.5 | 15.3 ± 1.1 |
Con | 26.2 ± 5.4 | 3/3 | 22.2 ± 3.1 | 60.5 ± 36.8 | 39.6 ± 4.5 | 0 ± 0 | 0 ± 0 | 15.3 ± 1.4 |
Values are reported as the mean ± SD, unless otherwise indicated. S, Study; V, visual cortex; A, anterior cingulate cortex; Con, control; M, male; F, female; BMI, body mass index; %PMHR, % of predicted maximum heart rate achieved during exercise; MaxW, maximum watts of exertion; MaxRPE, maximum rating of perceived exertion on a 0–10 scale (Noble et al. 1983); MRS onset, minutes after end of exercise when MRS data collection began.